Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: Decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A
Keywords: ipriflavone; M1, and M5; E. coli lipopolysaccharide; pharmacokinetics; expression of hepatic and intestinal CYP1A2 and 2C11; rats;